rs16975491

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.2193+75G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 1,453,128 control chromosomes in the GnomAD database, including 92,463 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 8866 hom., cov: 32)
Exomes 𝑓: 0.36 ( 83597 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.35

Publications

6 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 13-110181217-C-T is Benign according to our data. Variant chr13-110181217-C-T is described in ClinVar as Benign. ClinVar VariationId is 1293320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.364 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.2193+75G>A intron_variant Intron 29 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.2193+75G>A intron_variant Intron 29 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.340
AC:
51642
AN:
151884
Hom.:
8854
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.279
Gnomad AMI
AF:
0.559
Gnomad AMR
AF:
0.363
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.297
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.368
Gnomad OTH
AF:
0.356
GnomAD4 exome
AF:
0.356
AC:
462816
AN:
1301126
Hom.:
83597
AF XY:
0.357
AC XY:
233195
AN XY:
653972
show subpopulations
African (AFR)
AF:
0.270
AC:
8269
AN:
30640
American (AMR)
AF:
0.390
AC:
17175
AN:
44014
Ashkenazi Jewish (ASJ)
AF:
0.318
AC:
7967
AN:
25028
East Asian (EAS)
AF:
0.264
AC:
10224
AN:
38788
South Asian (SAS)
AF:
0.372
AC:
30702
AN:
82530
European-Finnish (FIN)
AF:
0.356
AC:
18883
AN:
53104
Middle Eastern (MID)
AF:
0.259
AC:
1357
AN:
5248
European-Non Finnish (NFE)
AF:
0.361
AC:
349013
AN:
966706
Other (OTH)
AF:
0.349
AC:
19226
AN:
55068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
13768
27535
41303
55070
68838
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10480
20960
31440
41920
52400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.340
AC:
51692
AN:
152002
Hom.:
8866
Cov.:
32
AF XY:
0.340
AC XY:
25289
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.279
AC:
11567
AN:
41460
American (AMR)
AF:
0.363
AC:
5551
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1188
AN:
3466
East Asian (EAS)
AF:
0.297
AC:
1539
AN:
5176
South Asian (SAS)
AF:
0.371
AC:
1789
AN:
4826
European-Finnish (FIN)
AF:
0.351
AC:
3698
AN:
10530
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.368
AC:
25001
AN:
67934
Other (OTH)
AF:
0.362
AC:
764
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1775
3550
5325
7100
8875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.354
Hom.:
1283
Bravo
AF:
0.338
Asia WGS
AF:
0.362
AC:
1256
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.010
DANN
Benign
0.40
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16975491; hg19: chr13-110833564; COSMIC: COSV65427750; API